Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „axitinib“
Suchtreffer
Begriffe & Kennungen
Inlyta · 4.5 · In vitro studies of CYP and UGT inhibition and induction In vitro studies indicated that axitinib does not inh
Eintrag öffnenInlyta · 4.5 · In vitro studies with P-glycoprotein In vitro studies indicated that axitinib inhibits P-glycoprotein. However
Eintrag öffnenInlyta · 4.8 · 11 Thyroid dysfunction (see section 4.4) In a controlled clinical study with axitinib for the treatment of pat
Eintrag öffnenInlyta · 4.8 · Arterial embolic and thrombotic events (see section 4.4) In a controlled clinical study with axitinib for the
Eintrag öffnenInlyta · 4.8 · Cardiac failure events (see section 4.4) In a controlled clinical study with axitinib (N = 359) for the treatm
Eintrag öffnenInlyta · 4.8 · Haemorrhage (see section 4.4) In a controlled clinical study with axitinib for the treatment of patients with
Eintrag öffnenInlyta · 4.8 · In monotherapy studies with axitinib (N = 672) for the treatment of patients with RCC, cardiac failure events
Eintrag öffnenInlyta · 4.8 · In pooled clinical studies with axitinib (N = 672) for the treatment of patients with RCC, arterial embolic an
Eintrag öffnenInlyta · 4.8 · In pooled clinical studies with axitinib (N = 672) for the treatment of patients with RCC, gastrointestinal pe
Eintrag öffnenInlyta · 4.8 · In pooled clinical studies with axitinib (N = 672) for the treatment of patients with RCC, haemorrhagic events
Eintrag öffnenInlyta · 4.8 · In pooled clinical studies with axitinib (N = 672) for the treatment of patients with RCC, hypothyroidism was
Eintrag öffnenInlyta · 4.8 · In pooled clinical studies with axitinib (N = 672) for the treatment of patients with RCC, polycythaemia was r
Eintrag öffnenInlyta · 4.8 · In pooled clinical studies with axitinib (N = 672) for the treatment of patients with RCC, venous embolic and
Eintrag öffnenInlyta · 4.8 · Table 1. Adverse reactions reported in RCC studies in patients who received axitinib (N = 672) All System orga
Eintrag öffnenInlyta · 4.8 · The most common (≥ 20%) adverse reactions observed following treatment with axitinib were diarrhoea, hypertens
Eintrag öffnenInlyta · 4.8 · Venous embolic and thrombotic events (see section 4.4) In a controlled clinical study with axitinib for the tr
Eintrag öffnenKeytruda · 4.8 · 17 MedDRA SOC Monotherapy In combination with In combination with and frequency chemotherapy, axitinib or lenv
Eintrag öffnenKeytruda · 4.8 · 177 MedDRA SOC Monotherapy In combination with In combination with and frequency chemotherapy, axitinib or len
Eintrag öffnenKeytruda · 4.8 · 178 MedDRA SOC Monotherapy In combination with In combination with and frequency chemotherapy, axitinib or len
Eintrag öffnenKeytruda · 4.8 · 179 MedDRA SOC Monotherapy In combination with In combination with and frequency chemotherapy, axitinib or len
Eintrag öffnen